Catalyst Capital Advisors Has Cut Cvs Health (CVS) Position; Last Week Avery Dennison (AVY) Coverage

January 18, 2018 - By Louis Casey

Catalyst Capital Advisors Llc decreased Cvs Health Corp (CVS) stake by 16.07% reported in 2017Q3 SEC filing. Catalyst Capital Advisors Llc sold 8,263 shares as Cvs Health Corp (CVS)’s stock declined 4.23%. The Catalyst Capital Advisors Llc holds 43,153 shares with $3.51 million value, down from 51,416 last quarter. Cvs Health Corp now has $81.10 billion valuation. The stock increased 0.69% or $0.55 during the last trading session, reaching $80.05. About 1.68M shares traded. CVS Health Corporation (NYSE:CVS) has declined 24.40% since January 18, 2017 and is downtrending. It has underperformed by 41.10% the S&P500.

Among 9 analysts covering Avery Dennison (NYSE:AVY), 4 have Buy rating, 0 Sell and 5 Hold. Therefore 44% are positive. Avery Dennison had 25 analyst reports since October 15, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Wednesday, June 21 by KeyBanc Capital Markets. The rating was upgraded by Bank of America to “Buy” on Tuesday, June 20. KeyBanc Capital Markets maintained the stock with “Hold” rating in Monday, October 23 report. The stock of Avery Dennison Corporation (NYSE:AVY) has “Hold” rating given on Tuesday, July 25 by KeyBanc Capital Markets. The firm has “Hold” rating by Loop Capital given on Thursday, October 26. The stock of Avery Dennison Corporation (NYSE:AVY) has “Buy” rating given on Thursday, October 26 by Robert W. Baird. Citigroup upgraded the shares of AVY in report on Friday, January 6 to “Buy” rating. The company was upgraded on Wednesday, December 7 by Bank of America. The firm earned “Neutral” rating on Friday, May 20 by JP Morgan. The firm has “Overweight” rating given on Monday, October 30 by Barclays Capital. See Avery Dennison Corporation (NYSE:AVY) latest ratings:

10/01/2018 Broker: Robert W. Baird Rating: Buy New Target: $125.0 Maintain
15/12/2017 Broker: Barclays Capital Rating: Buy New Target: $135.0
30/10/2017 Broker: Barclays Capital Rating: Overweight Old Target: $105 New Target: $120 Maintain
26/10/2017 Broker: Robert W. Baird Rating: Buy New Target: $115.0 Maintain
26/10/2017 Broker: Loop Capital Rating: Hold Old Target: $99 New Target: $106 Maintain
26/10/2017 Broker: JP Morgan Old Rating: Overweight New Rating: Neutral Downgrade
26/10/2017 Broker: J.P. Morgan Rating: Hold New Target: $101.0 Downgrade
23/10/2017 Broker: KeyBanc Capital Markets Rating: Hold Maintain
10/10/2017 Broker: Robert W. Baird Rating: Buy New Target: $100.0 Maintain
29/09/2017 Broker: Loop Capital Rating: Hold New Target: $99 Initiates Coverage On

The stock increased 0.92% or $1.09 during the last trading session, reaching $119.97. About 84,193 shares traded. Avery Dennison Corporation (NYSE:AVY) has risen 10.91% since January 18, 2017 and is uptrending. It has underperformed by 5.79% the S&P500.

Since August 3, 2017, it had 0 buys, and 4 sales for $3.45 million activity. $936,300 worth of stock was sold by Siewert Patrick on Thursday, August 3. On Tuesday, December 12 BARKER PETER K sold $229,510 worth of Avery Dennison Corporation (NYSE:AVY) or 2,000 shares. SCARBOROUGH DEAN A also sold $2.10 million worth of Avery Dennison Corporation (NYSE:AVY) shares. PYOTT DAVID E I sold $188,000 worth of stock.

Investors sentiment decreased to 0.92 in 2017 Q3. Its down 0.05, from 0.97 in 2017Q2. It turned negative, as 34 investors sold Avery Dennison Corporation shares while 167 reduced holdings. 50 funds opened positions while 134 raised stakes. 70.08 million shares or 2.56% less from 71.92 million shares in 2017Q2 were reported. Jpmorgan Chase Communication stated it has 0.01% in Avery Dennison Corporation (NYSE:AVY). Navellier Assoc has 36,995 shares for 0.71% of their portfolio. Tompkins Fincl holds 350 shares or 0.01% of its portfolio. Northern Tru invested in 1.16M shares. Exxonmobil Mngmt Inc Tx invested in 16,141 shares. Raymond James & Associate owns 144,291 shares for 0.03% of their portfolio. Globeflex Lp accumulated 9,708 shares. Spectrum Management Group Inc Inc stated it has 0.13% of its portfolio in Avery Dennison Corporation (NYSE:AVY). Eaton Vance holds 17,677 shares. Atlantic Tru Grp Inc Ltd Limited Liability Company holds 0.16% in Avery Dennison Corporation (NYSE:AVY) or 357,606 shares. Washington Trust Bancshares, Washington-based fund reported 267 shares. James Inv Rech Inc reported 1.56% stake. Charter reported 0.09% stake. Pnc Fin Ser Group stated it has 41,319 shares. First Interstate Bank & Trust invested 0% in Avery Dennison Corporation (NYSE:AVY).

Avery Dennison Corporation produces and sells pressure-sensitive materials worldwide. The company has market cap of $10.56 billion. The companyÂ’s Label and Graphic Materials segment offers pressure-sensitive labeling materials; packaging materials and solutions; roll-fed sleeves; engineered films; graphic imaging media; and reflective materials under the Fasson, JAC, and Avery Dennison brands. It has a 26.79 P/E ratio. It serves label converters, package designers, packaging engineers and manufacturers, industrial and sign manufacturers, printers, distributors, designers, advertising and government agencies, and graphics vendors.

Among 25 analysts covering CVS Health (NYSE:CVS), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. CVS Health had 65 analyst reports since July 22, 2015 according to SRatingsIntel. On Wednesday, November 9 the stock rating was maintained by Mizuho with “Buy”. Deutsche Bank maintained it with “Hold” rating and $121 target in Thursday, August 20 report. Robert W. Baird downgraded it to “Neutral” rating and $77 target in Thursday, February 2 report. The rating was maintained by Leerink Swann on Tuesday, November 21 with “Buy”. Morgan Stanley upgraded CVS Health Corporation (NYSE:CVS) on Friday, January 5 to “Overweight” rating. The firm earned “Buy” rating on Monday, January 8 by Leerink Swann. The stock of CVS Health Corporation (NYSE:CVS) has “Hold” rating given on Friday, September 8 by Needham. The firm has “Neutral” rating given on Monday, May 9 by Citigroup. Citigroup maintained CVS Health Corporation (NYSE:CVS) on Thursday, August 17 with “Neutral” rating. The rating was maintained by Jefferies with “Buy” on Thursday, May 12.

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on February, 8. They expect $1.90 earnings per share, up 11.11% or $0.19 from last year’s $1.71 per share. CVS’s profit will be $1.92B for 10.53 P/E if the $1.90 EPS becomes a reality. After $1.50 actual earnings per share reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts 26.67% EPS growth.

Catalyst Capital Advisors Llc increased Centene Corp Del (NYSE:CNC) stake by 5,100 shares to 37,100 valued at $3.59M in 2017Q3. It also upped Home Bancshares Inc (NASDAQ:HOMB) stake by 12,800 shares and now owns 26,900 shares. Apple Inc (NASDAQ:AAPL) was raised too.

Since August 16, 2017, it had 0 insider purchases, and 7 insider sales for $58.32 million activity. Shares for $7.19M were sold by Moriarty Thomas M. Another trade for 241,150 shares valued at $20.03M was sold by MERLO LARRY J. 237,078 shares were sold by Denton David M, worth $18.88 million on Monday, September 11. Shares for $7.13M were sold by Roberts Jonathan C. Shares for $3.22M were sold by Foulkes Helena on Friday, September 15. SWIFT RICHARD J also sold $199,050 worth of CVS Health Corporation (NYSE:CVS) shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.